Veterinary Medicines

Drontal, film coated tablet

Authorised
  • Pyrantel embonate
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Drontal, film coated tablet
DRONTAL CHAT
Active substance:
  • Pyrantel embonate
  • Praziquantel
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pyrantel embonate
    230.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    20.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • (ID5) 4 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 4 Film-coated tablet
  • (ID1) 2 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 2 Film-coated tablet
  • (ID8) 96 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 96 Film-coated tablet
  • (ID2) 20 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 20 Film-coated tablet
  • (ID4) 100 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 100 Film-coated tablet
  • (ID7) 24 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 24 Film-coated tablet
  • (ID9) 144 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 144 Film-coated tablet
  • (ID3) 6 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 6 Film-coated tablet
  • (ID6) 8 Film-coated tablet: unspecified outer container with 1 Cello pack (Aluminium; PolyEthylene) with 8 Film-coated tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/0272772 1/1996
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0101/001
Concerned member states:
  • France
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 16/02/2022
Download
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."